Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Modified mRNA Vaccines Using a Systems Biology Approach in Healthy Adults

NCT05397223 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT05397223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05397223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Modified mRNA Vaccines Using a Systems Biology Approach in Healthy Adults
Lead sponsor
ModernaTX, Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 24, 2022
Completion date
February 27, 2026
Enrollment
308 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus, respiratory syncytial virus, sars-cov-2, seasonal influenza